Report Categories
View AllRecent Articles
View All
Sst Stock Analysis System1 Inc. Falls 31.61 Pct To 3.57 Usd Amid Steep Selloff 20260403 1
The numbers behind Imperial IMPPP stock nobody talks about Investors Pile In 20260508
JRS Nuveen real estate income fund reports quarterly results amid rate environment uncertainty updates investors on portfolio strategy
ICG Intchains shares drop 3 after Q4 earnings miss widens to 2900 raising red flags on operations
Templeton TEI Management Strategy Q1 2026 Earnings Report
Netflix Inc NFLX Radford Studio Acquisition Talks Introduce New Valuation Dynamic for Streaming Leader
Global Q4 earnings miss by 61 percent GSL shares slip 125 percent amid challenging market
Humana Inc HUM Rides SectorWide Rally Following UnitedHealth Q1 Earnings Beat
Why Steel Dynamics STLD Stock Dropped Today Climbs 20260420
STLA Stellantis reports steep Q4 2025 EPS miss shares slide 204 percent as investor sentiment sours
AMAL Amalgamated reports Q1 2026 EPS below analyst estimates while its stock climbs modestly in todays trading
APAM Artisan shares gain more than two percent despite Q1 2026 earnings coming below consensus estimates
KLA Corporation KLAC UBS Raises Price Target Ahead of Fiscal Q3 2026 Earnings Release
Stock Market Slips as Rising Bond Yields Weigh on Tech Sector
Wholesale Inflation Surges 6 in April Marking Sharpest Annual Jump Since 2022
Veracyte VCYT Stock Today Rallies 076 Resistance at 4047 20260514
Triple TFPM Q1 2026 Beat Revenue NA EPS Exceeds by Significant
European Telecoms CEO Flags Growing Risk of US Dominance in Satellite and AI Sectors
abrdn Life Sciences Investors HQL Edges Higher as Sector Rotations Lift HealthcareFocused CEF
Meta Plans 6065 Billion AI Infrastructure Investment Signaling IndustryWide Spending Surge
Dana White Urges Trump to Revise Gambling Tax Law Prediction Markets React
Plus500 Revenue Climbs 11 in Latest Quarter Company Confirms Guidance
Novartis Lifts Annual Sales and Profit Outlook
Ledn Predicts 1 Trillion Market Potential for BitcoinBacked Loans
Trump Postpones AI Executive Order Signing Citing Aspects That Could Act as Blocker
Brainbees Solutions Narrows Q4 Loss as Firstcry Parent Reports 12 Revenue Growth
SpaceXs Deleted S1 Disclosure Reveals Stunning Economics of AI Infrastructure Deal with Anthropic
MBRX Q1 2026 Earnings EPS Misses Estimates as Development Costs Rise
XPEV Q4 2025 Earnings A Stunning Profit Beat Drives Shares Higher
Scienture Holdings Inc SCNX Q1 2026 Earnings Significant EPS Beat Highlights Cost Discipline and Operational Progress
WKHS Q1 2026 Earnings Wider Loss Than Expected Amid Ongoing Challenges
TrioTech International TRT Q3 2024 Earnings Modest Profit Reported Amidst Challenging Environment
Repligen Corporation RGEN Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Not Disclosed
Diamondback Energy FANG Edges Higher as Energy Sector Shows Resilience
Tennessee Valley Authority TVC Holds Steady Near 2407 Amid Narrow Trading Range
Greenwich LifeSciences Inc GLSI Edges Higher as Shares Approach Key Resistance
Replimune Group REPL Slides 644 as Biotech Shares Face Renewed Pressure
Korro Bio Inc KRRO Slips 225 as Stock Approaches Key Support Level
Lands End Inc LE Q1 2026 Earnings Earnings Miss Weighs on Sentiment Yet Stock Rises
Sonida Senior Living Inc SNDA Q1 2026 Earnings WiderThanExpected Loss Amid Operational Headwinds
SpaceXs Historic IPO Filing Reveals 55 Billion Loss and Elon Musks Tight Control
SNCY Q1 2026 Earnings EPS Miss Weighs on Airlines FirstQuarter Results
Gloo Holdings Inc GLOO Q4 2025 Earnings Narrowing Loss Drives Stock Rally Amid Strategic Pivot
External Links
Trump Approval Ratings Slip Below 39 in Four of Five Recent Polls
INTS Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Clinical Pipeline
SFL Corporation Ltd Slides 15 as Resistance Holds Firm at 1306
Gevo Inc GEVO Edges Higher as Shares Test Key Resistance Levels
CytomX Therapeutics CTMX Holds Steady Near Resistance After 325 Gain
BingEx FLX Shares Edge Higher Testing Resistance Zone
Lovesac LOVE Edges Higher as Stock Holds Above Key Support at 1558
Biodexa Pharmaceuticals BDRX Extends Gains Testing Key Resistance at 344
Alnylam Pharmaceuticals Slips Amid Sector Volatility Support and Resistance in Focus
ProQR Therapeutics PRQR Holds Steady Near 157 as Uplift Potential Remains